4.6 Review

Revisiting bleomycin from pathophysiology to safe clinical use

期刊

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 87, 期 1, 页码 90-100

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2012.12.003

关键词

Bleomycin; Hodgkin's Lymphoma; Testicular germ-cell tumour; Lung injury; Therapeutics; Safe clinical use; Toxicity

资金

  1. Hellenic Society of Haematology Foundation

向作者/读者索取更多资源

Bleomycin is a key component of curative chemotherapy regimens employed in the treatment of curable cancers, such as Hodgkin lymphoma (HL) and testicular germ-cell tumours (GCT), yet its use may cause bleomycin-induced lung injury (BILI), which is associated with significant morbidity and a mortality rate of 1-3%. Diagnosis of BILI is one of exclusion and physicians involved in the care of HL and GCT patients should be alerted. Pharmacogenomic studies could contribute towards the identification of molecular predictors of bleomycin toxicity on the aim to optimize individual use of bleomycin. We review all existing data on bleomycin's most recent integrated chemical biology, molecular pharmacology and mature clinical data and provide guidelines for its safe clinical use. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Hematology

Leishmaniasis mimicking multiple myeloma

Ioannis Papakonstantinou, Epameinondas Koumpis, Eugenia Fytsili, Aikaterini Panteli, Haralampos Milionis, Alexandra Papoudou-Bai, Eleni Kapsali, Eleftheria Hatzimichael

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)

Article Biochemistry & Molecular Biology

NMR and computational studies reveal novel aspects in molecular recognition of unsaturated fatty acids with non-labelled serum albumin

Eleni Alexandri, Alexandra Primikyri, Georgios Papamokos, Themistoklis Venianakis, Vasileios K. Gkalpinos, Andreas G. Tzakos, Andreas Karydis-Messinis, Dimitrios Moschovas, Apostolos Avgeropoulos, Ioannis P. Gerothanassis

Summary: This study presents a novel approach using STD, Tr-NOESY, INPHARMA NMR techniques, docking calculations, and competitive binding experiments to map the interactions and binding sites of free fatty acids (FFAs) with non-labelled serum albumin (BSA/HSA). The results reveal significant negative inter-ligand NOEs between the FFAs and the drugs ibuprofen and warfarin, suggesting a competitive binding mode. The conformational flexibility of the FFAs in the warfarin binding site hindered the accurate determination of their location and conformational states.

FEBS JOURNAL (2022)

Article Biochemistry & Molecular Biology

Serum albumin as a primary non-covalent binding protein for nitro-oleic acid

Lenka Hernychova, Eleni Alexandri, Andreas G. Tzakos, Martina Zatloukalova, Alexandra Primikyri, Ioannis P. Gerothanassis, Lukas Uhrik, Marek Sebela, David Kopecy, Lukas Jedinak, Jan Vacek

Summary: This work investigates the interaction between 9/10-nitro-oleic acid (NO2-OA) and human serum albumin (HSA). The study reveals that NO2-OA can non-covalently bind to HSA and has a higher affinity to HSA compared to oleic acid (OA).

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Pathology

Autophagy and cellular senescence in classical Hodgkin lymphoma

Lydia Kyriazopoulou, Georgia Karpathiou, Eleftheria Hatzimichael, Michel Peoc'h, Alexandra Papoudou-Bai, Panagiotis Kanavaros

Summary: This study investigated the expression of autophagy and cellular senescence in classical Hodgkin lymphoma and found a significant positive correlation between high nuclear p62 expression and disease relapse. Heterogeneous autophagy and cellular senescence patterns were observed in Hodgkin and Reed-Sternberg cells, suggesting biological heterogeneity in classical Hodgkin lymphoma.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Article Plant Sciences

Exploration of Betalains and Determination of the Antioxidant and Cytotoxicity Profile of Orange and Purple Opuntia spp. Cultivars in Greece

Antonios D. Tsiailanis, Christos M. Chatzigiannis, Christina D. Papaemmanouil, Maria Chatziathanasiadou, Panagiotis Chaloulos, Isabel Riba, Graham Mullard, Wieslaw Wiczkowski, Apostolos Koutinas, Ioanna Mandala, Andreas G. Tzakos

Summary: Replacing synthetic dyes with natural pigments, such as betalains, is a topic of great interest in the food industry, as consumers are increasingly concerned about non-toxic and natural additives. This study focuses on the identification of betalain phytochemical content in prickly pear cactus from two different Opuntia species in Greece. The use of modern analytical techniques, including UV-Vis spectroscopy, NMR spectroscopy, and LC-HRMS, as well as cell-based assays, enabled the researchers to establish a rapid approach for distinguishing different Opuntia cultivars based on their phytochemical constituents. These findings highlight the potential of Opuntia species as a viable source of natural food colorants.

PLANT FOODS FOR HUMAN NUTRITION (2022)

Article Multidisciplinary Sciences

Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma

Richard Perryman, Alexander Renziehausen, Hamidreza Shaye, Androniki D. Kostagianni, Antonis D. Tsiailanis, Thomas Thorne, Maria Chatziathanasiadou, Gregory B. Sivolapenko, Mohamed Ahmed El Mubarak, Gye Won Han, Barbara Zarzycka, Vsevolod Katritch, Guillaume Lebon, Cristiana Lo Nigro, Laura Lattanzio, Sophie Morse, James J. Choi, Kevin O'Neill, Zoi Kanaki, Apostolos Klinakis, Tim Crook, Vadim Cherezov, Andreas G. Tzakos, Nelofer Syed

Summary: This study reveals that AT(2)R is a therapeutic target for GBM and AngII promotes proliferation through this receptor. EMA401 and its derivative A3E can inhibit the proliferation and invasiveness of GBM, and show enhanced penetration in the CNS.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Oncology

Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era

Theodoros P. Vassilakopoulos, Fotios Panitsas, Zois Mellios, John Apostolidis, Michalis Michael, Ronit Gurion, Burhan Ferhanoglu, Eleftheria Hatzimichael, Stamatios Karakatsanis, Maria Dimou, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Hara Giatra, Nick Kanellias, Ayman Sayyed, Tamar Tadmor, Olga Meltem Akay, Maria K. Angelopoulou, Netanel Horowitz, Maria Bakiri, Gerassimos A. Pangalis, Panayiotis Panayiotidis, Sotirios G. Papageorgiou

Summary: Central nervous system (CNS) involvement is rare in primary mediastinal large B-cell lymphoma (PMLBCL). Kidney and/or adrenal involvement is strongly associated with CNS relapse. Chemotherapy regimen and established prognostic factors do not predict CNS relapse in PMLBCL. CNS relapse as a first event occurs rarely in PMLBCL.

HEMATOLOGICAL ONCOLOGY (2023)

Article Multidisciplinary Sciences

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome

Panagiotis T. Diamantopoulos, Emmanouil Charakopoulos, Argiris Symeonidis, Ioannis Kotsianidis, Nora-Athina Viniou, Vassiliki Pappa, Charalampos Pontikoglou, Dimitrios Tsokanas, Georgios Drakos, Alexandra Kourakli, Elena Solomou, Eleftheria Hatzimichael, Anastasia Pouli, Maria Kotsopoulou, Evangelos Asmanis, Maria Dimou, Panayiotis Panayiotidis, Sotirios Papageorgiou, Georgios Vassilopoulos, Achilles Anagnostopoulos, Theodoros Vassilakopoulos, Helen Papadaki, Athanasios Galanopoulos

Summary: Monocytopenia is a common finding in patients with myelodysplastic syndrome (MDS), and its presence is associated with excess blasts and higher prognostic scoring system categories. Monocytopenia is a prognostic indicator of lower overall survival and leukemia free survival in MDS patients, even after adjusting for other factors. Monocytopenia can also help differentiate prognostically distinct subgroups in the low and intermediate risk groups of MDS.

SCIENTIFIC REPORTS (2022)

Article Immunology

Phenethyl ester of rosmarinic acid ameliorates experimental autoimmune encephalomyelitis

Goran Stegnjaic, Milica Lazarevic, Dimitrios A. Diamantis, Neda Djedovic, Bojan Jevtic, Suzana Stanisavljevic, Mirjana Dimitrijevic, Miljana Momcilovic, Andreas G. Tzakos, Dorde Miljkovic

Summary: This study evaluated the immunomodulatory properties of a phenethyl ester derivative of rosmarinic acid (PERA) in an animal model of central nervous system autoimmunity. PERA was found to have anti-encephalitogenic effects by shortening disease duration and reducing clinical scores, as well as inhibiting the production of encephalitogenic cytokines and nitric oxide. The study suggests that PERA could be a potential therapy for multiple sclerosis.

IMMUNOLOGY LETTERS (2022)

Article Oncology

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries

Konstantinos Liapis, Vasileios Papadopoulos, Charalambos Pontikoglou, George Vrachiolias, Emily Stavroulaki, Alexandra Kourakli, Vasileios Lazaris, Athanasios G. Galanopoulos, Menelaos Papoutselis, Sotirios G. Papageorgiou, Panagiotis T. Diamantopoulos, Vassiliki Pappa, Nora-Athina Viniou, Dimitris Tsokanas, Theodoros P. Vassilakopoulos, Eleftheria Hatzimichael, Eleni Bouronikou, Maria Ximeri, Aekaterini Megalakaki, Panagiotis Zikos, Panayiotis Panayiotidis, Maria Dimou, Stamatis Karakatsanis, Maria Papaioannou, Stavros Papadakis, Anna Vardi, Flora Kontopidou, Nikolaos Harchalakis, Ioannis Adamopoulos, Argiris Symeonidis, Helen A. Papadaki, Ioannis Kotsianidis

LEUKEMIA (2023)

Letter Hematology

The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms

Panagiotis T. Diamantopoulos, Elena Solomou, Argiris Symeonidis, Vasiliki Pappa, Ioannis Kotsianidis, Athanasios Galanopoulos, Charalampos Pontikoglou, Achilles Anagnostopoulos, George Vassilopoulos, Panagiotis Zikos, Eleftheria Hatzimichael, Maria Papaioannou, Aekaterini Megalakaki, Theodoros Vassilakopoulos, Maria Dimou, Dimitrios Tsokanas, Menelaos-Konstantinos Papoutselis, Sotirios Papageorgiou, Alexandra Kourakli, Helen Papadaki, Panayiotis Panayiotidis, Nora-Athina Viniou

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Review Biology

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications

Vasileios Georgoulis, Alexandra Papoudou-Bai, Alexandros Makis, Panagiotis Kanavaros, Eleftheria Hatzimichael

Summary: Hodgkin lymphoma accounts for 10% of new lymphoma diagnoses and has high cure rates, but new treatments are needed for relapsed cases. Neoplastic cells in the tumor microenvironment interact with immune cells and suppress the host's anti-tumor immunity. This review summarizes the role of different cells in the microenvironment, focusing on macrophages, and discusses how tumor cells evade immune surveillance. Novel therapeutic targets have been identified in this microenvironment, providing personalized treatment options for Hodgkin lymphoma patients.

BIOLOGY-BASEL (2023)

Review Medicine, Research & Experimental

Primary Bone Lymphoma: A Review of the Literature with Emphasis on Histopathology and Histogenesis

Theofilos Kanavos, Effrosyni Birbas, Alexandra Papoudou-Bai, Eleftheria Hatzimichael, Aikaterini Kitsouli, Georgia Karpathiou, Panagiotis Kanavaros

Summary: Primary bone lymphoma (PBL) is a rare form of malignant lymphoid cell tumor that presents with bone lesions without nodal or extranodal involvement. The most common histological type is diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), and it primarily occurs in the femur, humerus, tibia, spine, and pelvis. Diagnosis is often delayed due to non-specific clinical presentation, but can be confirmed through clinical examination, imaging studies, and histopathological and immunohistochemical examination. PBL has a favorable prognosis, especially when treated with combined chemoradiotherapy.

DISEASES (2023)

Article Medicine, Research & Experimental

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma

Stamatis J. Karakatsanis, Maria Bouzani, Argyris Symeonidis, Maria K. Angelopoulou, Sotirios G. Papageorgiou, Michail Michail, Gabriella Gainaru, Georgia Kourti, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, Nick Kanellias, Maria N. Dimopoulou, Evridiki Michali, George Karianakis, Pantelis Tsirkinidis, Chryssa Vadikolia, Christos Poziopoulos, Anna Pigaditou, Effimia Vrakidou, Theophanis Economopoulos, Lydia Kyriazopoulou, Marina P. Siakantaris, Marie-Christine Kyrtsonis, Konstantinos Anargyrou, Maria Papaioannou, Evdoxia Hatjiharissi, Elissavet Vervessou, Maria Tsirogianni, Maria Palassopoulou, Ekaterini Stefanoudaki, Panayiotis Zikos, Panayiotis Tsirigotis, Gerassimos Tsourouflis, Theodora Assimakopoulou, Evgenia Verrou, Helen Papadaki, Polixeni Lampropoulou, Meletios-Athanasios Dimopoulos, Vassiliki Pappa, Kostas Konstantopoulos, Themis Karmiris, Paraskevi Roussou, Panayiotis Panayiotidis, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos

Summary: Both R-CHOP-14 and R-CHOP-21 are likely equally effective in PMLBCL patients, but further studies are needed to determine if dose-dense regimens can provide better disease control and long-term outcomes.

IN VIVO (2022)

Review Medicine, Research & Experimental

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Georgios Petros Barakos, Eleftheria Hatzimichael

Summary: Bone marrow, as an active organ of the immune system, provides a sanctuary for immune cells and responds to external stimuli. However, chronic immune stimulation is harmful to normal hematopoietic stem cells, while essential for the propagation of dysregulated immune microenvironments in myeloid diseases.

DISEASES (2022)

Review Oncology

cGAS-STING at the crossroads in cancer therapy

Rui Wang, Aashiq Hussain, Quanquan Guo, Meimei Ma

Summary: DNA is highly immunogenic and can activate the cGAS-STING pathway, which plays a crucial role in the pathogenesis and progression of neoplastic diseases. The modulation of cGAS-STING signaling holds great promise for cancer therapy, although there are disagreements on whether to activate or inhibit this pathway.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies

Ali Zarezadeh Mehrabadi, Faezeh Shahba, Hossein Khorramdelazad, Nazanin Aghamohammadi, Milad Karimi, Kowsar Bagherzadeh, Majid Khoshmirsafa, Ramin Massoumi, Reza Falak

Summary: IL-1 receptor accessory protein (IL-1RAP) plays a crucial role in inflammatory conditions and tumorigenesis in the tumor microenvironment. It is involved in the progression, metastasis, and angiogenesis of solid tumors and hematological malignancies.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy

Xiao Tang, Yujie Niu, Jinli Jian, Yuancheng Guo, Yin Wang, Yu Zhu, Bei Liu

Summary: Ferroptosis is an iron-dependent form of cell death that promotes tumor cell death by causing cell membrane rupture and accumulation of lipid peroxides. Extensive research has been conducted to explore the mechanism of ferroptosis inducers, but its role in hematological tumors is still limited.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation study

Tanwei Yuan, Dominic Edelmann, Jakob N. Kather, Ziwen Fan, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge-Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Blaeker, Barbara Burwinkel, Hermann Brenner, Michael Hoffmeister

Summary: The study aimed to analyze and validate previously published CpG-methylation-based prognostic biomarkers and prediction models for colorectal cancer (CRC) prognosis. The results showed that the discrimination ability of the models was insufficient and lacked clinical relevance.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

Advances, opportunities and challenges in developing therapeutic cancer vaccines

Zhihui Duan, Dandan Yang, Ping Yuan, Xiaoming Dai, Guodong Chen, Daichao Wu

Summary: This article provides a comprehensive overview of therapeutic cancer vaccines, including their classification, clinical application, efficacy, and combination strategies with other therapies. It offers a valuable theoretical basis for the future clinical application and development of therapeutic cancer vaccines.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)